These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18564619)

  • 41. [The prevention of vomiting due to antineoplastic chemotherapy in the elderly cancer patient].
    Santini D; Vincenzi B; Finolezzi E; Di Cosimo S; Gravante G; Spoto S; Tonini G
    Minerva Med; 1999; 90(7-8):205-9. PubMed ID: 10719419
    [No Abstract]   [Full Text] [Related]  

  • 42. [Prophylactic management for adverse events of cancer chemotherapy].
    Hanibuchi M; Nishioka Y
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():93-7. PubMed ID: 25831730
    [No Abstract]   [Full Text] [Related]  

  • 43. Chemotherapy-induced nausea and vomiting: state of the art in 2006.
    Schwartzberg L
    J Support Oncol; 2006 Feb; 4(2 Suppl 1):3-8. PubMed ID: 16499138
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemotherapy-induced nausea and vomiting.
    Rittenberg CN; Cunningham RS
    Clin J Oncol Nurs; 2005 Apr; 9(2):257-60. PubMed ID: 15853171
    [No Abstract]   [Full Text] [Related]  

  • 45. [Croatian guideliness for prevention of chemotherapy induced nausea and vomiting].
    Tomek R; Vrdoljak E; Vrbanec D; Nemet D; Matković V; Plestina S; Gugić D; Dintinjana RD; Bolanca A; Samarzija M; Petković M
    Lijec Vjesn; 2009; 131(3-4):49-53. PubMed ID: 19514248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relieving nausea and vomiting in patients with cancer: a treatment algorithm.
    Johnson MH; Moroney CE; Gay CF
    Oncol Nurs Forum; 1997; 24(1):51-7. PubMed ID: 9007907
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The prevention of nausea and vomiting induced by antineoplastic chemotherapy: the state of the art].
    Roila F; Tonato M; Del Favero A
    Riv Inferm; 1991; 10(1):40-3. PubMed ID: 1853098
    [No Abstract]   [Full Text] [Related]  

  • 48. Preventing chemotherapy-induced nausea and vomiting: an update and a review of emesis.
    Ettinger DS
    Semin Oncol; 1995 Aug; 22(4 Suppl 10):6-18. PubMed ID: 7570053
    [No Abstract]   [Full Text] [Related]  

  • 49. Chemotherapy-induced nausea and vomiting.
    Hesketh PJ
    N Engl J Med; 2008 Jun; 358(23):2482-94. PubMed ID: 18525044
    [No Abstract]   [Full Text] [Related]  

  • 50. [Palonosetron in the prevention of chemotherapy-induced nausea and vomiting (CINV) in Italy: pharmacologic, clinical and economic aspects].
    Pradelli L; Eandi M
    Tumori; 2008; 94(2):suppl 26-32. PubMed ID: 18564623
    [No Abstract]   [Full Text] [Related]  

  • 51. Anticipatory nausea and vomiting associated with cancer chemotherapy.
    Weddington WW; Miller NJ; Sweet DL
    N Engl J Med; 1982 Sep; 307(13):825-6. PubMed ID: 6287263
    [No Abstract]   [Full Text] [Related]  

  • 52. Delayed chemotherapy-induced nausea and vomiting in autologous hematopoietic cell transplant patients: an exploratory analysis.
    Gonella S; Di Giulio P
    Tumori; 2015 Nov; 101(6):e154-9. PubMed ID: 26045114
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Myths and realities of antiemetic treatment.
    Martin M
    Br J Cancer Suppl; 1992 Dec; 19():S46-50; discussion S50-3. PubMed ID: 1467202
    [No Abstract]   [Full Text] [Related]  

  • 54. [Comparative evaluation of 2 antiemesis tools for the prevention of chemotherapy-induced nausea and vomiting].
    Murata H; Teramoto Y; Kawashita M; Oi M; Kitaguchi T; Sasahira E; Masuda A; Satake Y; Enomoto S; Komai C; Udo M; Komuta K; Yamamoto K
    Gan To Kagaku Ryoho; 2014 Mar; 41(3):341-5. PubMed ID: 24743280
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Rational and methods of using antiemetics in the treatment of colorectal cancer].
    Roila F
    Tumori; 2001; 87(1 Suppl 1):S41-2. PubMed ID: 11300021
    [No Abstract]   [Full Text] [Related]  

  • 56. Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study.
    De Tursi M; Carella C; Tomao S; Cinieri S; Lorusso V; Marchetti P; Vecchio S; Sansoni E; Contu A; Adamo V; Silvestris N; Nuzzo A; Rosti G; Ravaioli A; Danova M; Tonini G; Passalacqua R; Cruciani G; Faedi M; Spada M; De Laurentiis M; Amoroso D; Tomao F; Sperduti I; Grassadonia A; Tinari N; Natoli C; Iacobelli S;
    Tumori; 2014; 100(6):e309-13. PubMed ID: 25688518
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The safety of antiemetic medications for the prevention of chemotherapy-induced nausea and vomiting.
    Navari RM
    Expert Opin Drug Saf; 2016; 15(3):343-56. PubMed ID: 26699406
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rolapitant for the treatment of chemotherapy-induced nausea and vomiting.
    Navari RM
    Expert Rev Anticancer Ther; 2015; 15(10):1127-33. PubMed ID: 26366937
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [1 year's use of alizapride for the prevention and treatment of nausea and vomiting secondary to anticancer agents].
    Olivier JP
    Ann Gastroenterol Hepatol (Paris); 1985 Jan; 21(1):53-5. PubMed ID: 3977279
    [No Abstract]   [Full Text] [Related]  

  • 60. Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
    Rubenstein EB
    Clin Adv Hematol Oncol; 2004 May; 2(5):284-9. PubMed ID: 16163194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.